Companies / Vor Biopharma Inc. / Activity
Activity — Vor Biopharma Inc.
11 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common stock | $20.57M | +1.2M | 1,153,276 1.95% of shares | medium |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | Common stock | $2.30M | +129K | 128,839 0.22% of shares | low |
| Q1 2026 as of | Axiom Investors LLC /De 13F manager | New | Common stock | $1.71M | +96K | 95,745 0.16% of shares | low |
| Q1 2026 as of | Rafferty Asset Management, LLC 13F manager | New | Common stock | $901.0K | +51K | 50,505 0.09% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common stock | $742.9K | +40K | 40,351 0.07% of shares | low |
| Q4 2025 as of | Johnson & Johnson 13F manager | New | Common stock | $702.8K | +54K | 53,732 0.09% of shares | low |
| Q1 2026 as of | Profund Advisors LLC 13F manager | New | Common stock | $392.7K | +22K | 22,015 0.04% of shares | low |
| Q4 2025 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $141.2K | +11K | 10,798 0.02% of shares | low |
| Q2 2026 as of | Pinnacle Wealth Planning Services, Inc. 13F manager | New | Common stock | $36.4K | +2K | 1,975 <0.01% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | New | Common stock | $18.3K | +1K | 1,399 <0.01% of shares | low |
| Q2 2026 as of | The PNC Financial Services Group, Inc. 13F manager | New | Common stock | $5.7K | +308 | 308 <0.01% of shares | low |